Keyword: Jean-Paul Clozel
News
13.06.2017
- The European Commission has approved plans by US healthcare group Johnson & Johnson to acquire Swiss biotech Actelion, thus completing all global regulatory approvals. J&J said it...
News
18.04.2013
- Actelion shareholders rejected a $5.6 million pay award for the biotechnology company's chief executive Jean-Paul Clozel on Thursday, making it the second Swiss company in as many...
News
25.05.2012
- Knock-out data for Actelion's big new drug hope could be a double-edged sword for embattled founder and CEO Jean-Paul Clozel, making it a worthy buy for pharma companies hungry for...
News
07.06.2011
- Actelion, Europe's largest biotech company which has been under pressure from activist investor Elliott Advisors, is changing its management structure, including appointing a chief...
News
02.05.2011
- Swiss biotech group Actelion is now facing a tougher battle at its annual general meeting this week after a jury decided Asahi Kasei Pharma Corporation should be awarded up to $547...
News
09.03.2011
- Swiss biotech group Actelion published a white paper defending its corporate governance as it aims to counter criticism from its largest shareholder Elliott Advisers ahead of a...
